Zobrazeno 1 - 10 of 11 pro vyhledávání: '"N H, Holländer"'
1
Prognostic implications of ventricular ectopy one week, one month, and sixteen months after an acute myocardial infarction
Autor: Bjarne Sigurd, Kresten Mellemgaard, Merrete Vaage‐Nilsen, Ingolf Nielsen, Jørgen Fischer Hansen, Ole Pedersen‐Bjergaard, Verner Rasmussen, N. H. Holländer, Margit Borring Sørensen, Leif Hagerup
Publikováno v: Clinical Cardiology. 21:905-911
Background: Ventricular ectopy early after an acute myocardial infarction (AMI) has previously been demonstrated to predict mortality. Less information is available about the prognostic implications of ventricular ectopy occurring late after an AMI,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::844837fa70c8123db2ca823bd0baafc9
https://doi.org/10.1002/clc.4960211209
Zobrazit plný text záznamu
2
Effect of verapamil on arrhythmias and heart rate during 16 months following an acute myocardial infarction
Autor: Kresten Mellemgaard, Jørgen Fischer Hansen, Merete Vaage-Nilsen, N. H. Holländer, Margit Borring Sørensen, Bjarne Sigurd, Leif Hagerup, Verner Rasmussen, Ingolf Nielsen, Ole Pedersen-Bjergaard
Publikováno v: Cardiovascular Drugs and Therapy. 8:147-151
The present study was a prospectively planned subset of the postinfarction, double blind, randomized, multicenter, placebo controlled trial of verapamil, DAVIT II. Patients had 24 hours of Holter monitoring before randomization, i.e., second week aft
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51efd516e00b4a838bb4cb12ceff5645
https://doi.org/10.1007/bf00877103
Zobrazit plný text záznamu
3
Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil
Autor: Merete Vaage-Nilsen, J. Fischer Hansen, V. Rasmussen, N. H. Holländer
Publikováno v: European Heart Journal. 13:666-670
DAVIT-II is a double-blind, randomized, multicentre, placebo-controlled study of long-term treatment with verapamil 360 mg per day administered to patients who have suffered an acute myocardial infarction (AMI). In the present study, comprising a sub
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c84bdfe3a18162c75c89ee42d130decb
https://doi.org/10.1093/oxfordjournals.eurheartj.a060233
Zobrazit plný text záznamu
5
Prognostic implications of ventricular ectopy one week, one month, and sixteen months after an acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction
Autor: M, Vaage-Nilsen, V, Rasmussen, J F, Hansen, L, Hagerup, M B, Sørensen, O, Pedersen-Bjergaard, K, Mellemgaard, N H, Holländer, I, Nielsen, B M, Sigurd
Publikováno v: Clinical cardiology. 21(12)
Background: Ventricular ectopy early after an acute myocardial infarction (AMI) has previously been demonstrated to predict mortality. Less information is available about the prognostic implications of ventricular ectopy occurring late after an AMI,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e48d84644370c6c7667b31a38cf72406
https://pubmed.ncbi.nlm.nih.gov/9853183
Zobrazit plný text záznamu
6
Effect of verapamil on arrhythmias and heart rate during 16 months following an acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction
Autor: M, Vaage-Nilsen, V, Rasmussen, J F, Hansen, L, Hagerup, M B, Sørensen, O, Pedersen-Bjergaard, K, Mellemgaard, N H, Holländer, I, Nielsen, B M, Sigurd
Publikováno v: Cardiovascular drugs and therapy. 8(1)
The present study was a prospectively planned subset of the postinfarction, double blind, randomized, multicenter, placebo controlled trial of verapamil, DAVIT II. Patients had 24 hours of Holter monitoring before randomization, i.e., second week aft
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e36d5419cc29b678076c92e5f7572674
https://pubmed.ncbi.nlm.nih.gov/8086325
Zobrazit plný text záznamu
7
[The circulating occupational medical record in the county of Roskilde]
Autor: T, Brendstrup, N H, Holländer, O, Christensen, P, Gregersen, F, Jensen
Publikováno v: Ugeskrift for laeger. 155(41)
The aim of the circulating occupational medical record (COMR) is to coordinate activities and documents concerning the patient who has an occupational disease. This new case record belongs to the patient, which solves the problems concerning the prof
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::00e14f152bcf7386dbe511402db27484
https://pubmed.ncbi.nlm.nih.gov/8256324
Zobrazit plný text záznamu
8
Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial Infarction
Autor: M, Vaage-Nilsen, V, Rasmussen, N H, Holländer, J F, Hansen
Publikováno v: European heart journal. 13(5)
DAVIT-II is a double-blind, randomized, multicentre, placebo-controlled study of long-term treatment with verapamil 360 mg per day administered to patients who have suffered an acute myocardial infarction (AMI). In the present study, comprising a sub
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::38f2624ef7c04ddfddb2dab29060c860
https://pubmed.ncbi.nlm.nih.gov/1618211
Zobrazit plný text záznamu
9
Effect of verapamil on ischemia and ventricular arrhythmias after an acute myocardial infarction: prognostic implications. The Danish Verapamil Infarction Trial II Study Group
Autor: M, Vaage-Nilsen, V, Rasmussen, J F, Hansen, L, Hagerup, M B, Sørensen, O P, Bjergaard, K, Mellemgaard, N H, Holländer, I, Nielsen, B, Sigurd
Publikováno v: Journal of cardiovascular pharmacology. 18
This article is a review of presented subsets of the Danish Verapamil Infarction Trial II (DAVIT II) regarding the effect of verapamil on postinfarction ischemia, ventricular arrhythmias, and heart rate (HR), and the prognostic implications of these
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1ebc3632b687fbcc232bb65e56144c61
https://pubmed.ncbi.nlm.nih.gov/1725913
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje